Answers are grounded in this paper and cite their sources.
OBJECTIVE: variants in the risk for isolated REM sleep behavior disorder (iRBD) and conversion to overt neurodegeneration. METHODS: variants on the risk of iRBD, age at onset (AAO), and conversion rates. RESULTS: variant carriers. However, the results on AAO and conversion were based on small numbers and should be interpreted with caution. CONCLUSIONS: variant carriers who will develop a synucleinopathy in the future.
No takes yet. Share an insight, caveat, or question.
Krohn et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: